This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Smilenov, L. B. Articles by Hall, E. J. Search for Related Content PubMed PubMed Citation Articles by Smilenov, L. B. Articles by Hall, E. J.

Modest Increased Sensitivity to Radiation Oncogenesis in ATM Heterozygous versus Wild-Type Mammalian Cells¹

Center for Radiological Research, Columbia University, New York, New York 10032

Subpopulations that are genetically predisposed to radiation-induced cancer could have significant public health consequences. Individuals homozygous for null mutations at the ataxia telangiectasia gene are indeed highly radiosensitive, but their numbers are very small. Ataxia Telangiectasia heterozygotes (1–2% of the population) have been associated with somewhat increased radiosensitivity for some end points, but none directly related to carcinogenesis. Here, intralitter comparisons between wild-type mouse embryo fibroblasts and mouse embryo fibroblasts carrying ataxia telangiectasia mutated (ATM) null mutation indicate that the heterozygous cells are more sensitive to radiation oncogenesis than their normal, litter-matched, counterparts. From these data we suggest that Ataxia Telangiectasia heterozygotes could indeed represent a societally-significant radiosensitive human subpopulation.

This article has been cited by other articles:

				Y. Bhuller, W. Jeng, and P. G. Wells Variable In Vivo Embryoprotective Role for Ataxia-Telangiectasia-Mutated against Constitutive and Phenytoin-Enhanced Oxidative Stress in Atm Knockout Mice Toxicol. Sci., September 1, 2006; 93(1): 146 - 155. [Abstract] [Full Text] [PDF]

				Y. Bhuller and P. G. Wells A Developmental Role for Ataxia-Telangiectasia Mutated in Protecting the Embryo from Spontaneous and Phenytoin-Enhanced Embryopathies in Culture Toxicol. Sci., September 1, 2006; 93(1): 156 - 163. [Abstract] [Full Text] [PDF]

				L. B. Travis, C. S. Rabkin, L. M. Brown, J. M. Allan, B. P. Alter, C. B. Ambrosone, C. B. Begg, N. Caporaso, S. Chanock, A. DeMichele, et al. Cancer Survivorship--Genetic Susceptibility and Second Primary Cancers: Research Strategies and Recommendations J Natl Cancer Inst, January 4, 2006; 98(1): 15 - 25. [Abstract] [Full Text] [PDF]

				M. Ozsahin, N. E.A. Crompton, S. Gourgou, A. Kramar, L. Li, Y. Shi, W. J. Sozzi, A. Zouhair, R. O. Mirimanoff, and D. Azria CD4 and CD8 T-Lymphocyte Apoptosis Can Predict Radiation-Induced Late Toxicity: A Prospective Study in 399 Patients Clin. Cancer Res., October 15, 2005; 11(20): 7426 - 7433. [Abstract] [Full Text] [PDF]

				D. Wu, H. Yang, W. Xiang, L. Zhou, M. Shi, G. Julies, J. M. LaPlante, B. R. Ballard, and Z. Guo Heterozygous mutation of ataxia-telangiectasia mutated gene aggravates hypercholesterolemia in apoE-deficient mice J. Lipid Res., July 1, 2005; 46(7): 1380 - 1387. [Abstract] [Full Text] [PDF]

				L. B. Smilenov, H. B. Lieberman, S. A. Mitchell, R. A. Baker, K. M. Hopkins, and E. J. Hall Combined Haploinsufficiency for ATM and RAD9 as a Factor in Cell Transformation, Apoptosis, and DNA Lesion Repair Dynamics Cancer Res., February 1, 2005; 65(3): 933 - 938. [Abstract] [Full Text] [PDF]

				D. J. Brenner, R. Doll, D. T. Goodhead, E. J. Hall, C. E. Land, J. B. Little, J. H. Lubin, D. L. Preston, R. J. Preston, J. S. Puskin, et al. Cancer risks attributable to low doses of ionizing radiation: Assessing what we really know PNAS, November 25, 2003; 100(24): 13761 - 13766. [Abstract] [Full Text] [PDF]